Sale!

CLCNKB Gene Bartter Syndrome Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CLCNKB Gene Bartter Syndrome Type 3 Genetic Test” is a specialized diagnostic procedure designed to identify mutations in the CLCNKB gene, which are responsible for causing Bartter Syndrome Type 3. This rare, inherited condition affects the kidneys’ ability to properly reabsorb salt, leading to imbalances in electrolytes, including potassium, chloride, and bicarbonate levels in the blood. Symptoms often manifest from infancy or early childhood and can include frequent urination, thirst, weakness, and growth delays.

This genetic test is a crucial tool for confirming a diagnosis of Bartter Syndrome Type 3, enabling healthcare providers to tailor treatment plans to manage symptoms effectively and improve the quality of life for affected individuals. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves analyzing a sample of the patient’s DNA to look for specific mutations in the CLCNKB gene.

The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with this condition. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for informed medical decisions and personalized care strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLCNKB Gene Bartter Syndrome Type 3 Genetic Test

Introduction

The CLCNKB Gene Bartter Syndrome Type 3 Genetic Test offered by DNA Labs UAE is a comprehensive genetic test that analyzes the CLCNKB gene to identify mutations associated with Bartter syndrome type 3. This rare genetic disorder affects the kidneys’ ability to reabsorb salt and maintain electrolyte balance.

Test Details

The CLCNKB gene is responsible for producing a protein called chloride channel, voltage-sensitive Kb. This protein plays a crucial role in maintaining the balance of chloride ions in the kidneys. Mutations in the CLCNKB gene can lead to Bartter syndrome type 3.

Symptoms and Diagnosis

Bartter syndrome type 3 is characterized by various symptoms related to electrolyte imbalances, such as excessive urination, dehydration, muscle weakness, and growth delays. Diagnosis of Bartter syndrome type 3 involves genetic testing, specifically NGS (Next-Generation Sequencing) technology, which can analyze multiple genes simultaneously to identify CLCNKB gene mutations.

Test Components and Price

  • Test Name: CLCNKB Gene Bartter Syndrome Type 3 Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology, Nephrology, Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CLCNKB Gene Bartter Syndrome Type 3 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by Bartter syndrome type 3 and the CLCNKB gene mutation.

Importance of Genetic Testing

NGS genetic testing plays a crucial role in diagnosing Bartter syndrome type 3 and providing valuable information for the management and treatment of the condition. It can also be used for carrier testing and family planning purposes. However, it is essential that genetic testing is performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate counseling and guidance based on the results.

Conclusion

The CLCNKB Gene Bartter Syndrome Type 3 Genetic Test offered by DNA Labs UAE is a comprehensive and reliable genetic test that can help diagnose Bartter syndrome type 3 and provide valuable insights for the management and treatment of the condition. By identifying mutations in the CLCNKB gene, this test plays a crucial role in improving patient outcomes and facilitating informed decision-making for family planning.

Test Name CLCNKB Gene Bartter syndrome type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLCNKB Gene Bartter syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCNKB Gene Bartter syndrome type 3 NGS Genetic DNA Test gene CLCNKB
Test Details

The CLCNKB gene is responsible for producing a protein called chloride channel, voltage-sensitive Kb, which is involved in maintaining the balance of chloride ions in the kidneys. Mutations in the CLCNKB gene can lead to a condition called Bartter syndrome type 3.

Bartter syndrome is a rare genetic disorder that affects the kidneys’ ability to reabsorb salt and maintain the body’s electrolyte balance. There are several types of Bartter syndrome, and type 3 is caused by mutations in the CLCNKB gene.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular condition. In the case of Bartter syndrome type 3, NGS genetic testing can be used to identify mutations in the CLCNKB gene.

By identifying specific mutations in the CLCNKB gene, NGS genetic testing can help diagnose Bartter syndrome type 3 and provide valuable information for the management and treatment of the condition. It can also be used for carrier testing and family planning purposes.

It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate counseling and guidance based on the results.